Canna~Fangled Abstracts The challenges of ‘medical cannabis’ and mental health: a clinical perspective. Br J Clin Pharmacol. 2018 Jun 20. doi: 10.1111/bcp.13687. Newton-Howes G1. Author information Abstract The…Freedom WaresJune 20, 2018
Canna~Fangled Abstracts Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC Journal List Med Cannabis Cannabinoids v.1(1); 2018 Jun PMC8489354 As a library, NLM provides access…Freedom WaresJune 16, 2018
Canna~Fangled Abstracts The Endocannabinoid System, Our Universal Regulator Research June 1, 2018 Access PDF AUTHORS: CHAD A. SALLABERRY AND LAURIE ASTERN Institutions: Department of…Freedom WaresJune 16, 2018
Canna~Fangled Abstracts Agricultural innovations in Morocco’s cannabis industry. Int J Drug Policy. 2018 Jun 6;58:85-91. doi: 10.1016/j.drugpo.2018.04.013. Chouvy PA1, Macfarlane J2. Author information…Freedom WaresJune 6, 2018
Canna~Fangled Abstracts Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington’s Disease. Methods Mol Biol. 2018;1780:549-571. doi: 10.1007/978-1-4939-7825-0_25. Bagher AM1,2, Laprairie RB1,3, Kelly MEM1,4, Denovan-Wright EM5. Author…Freedom WaresJune 2, 2018
Canna~Fangled Abstracts Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington’s disease. Neuropsychopharmacology. 2018 Jun 1. doi: 10.1038/s41386-018-0107-8. Covey DP1, Dantrassy HM1, Yohn SE2,3, Castro A1, Conn…Freedom WaresJune 1, 2018
Canna~Fangled Abstracts Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an ‘index’ for monitoring and evaluation. J Public Health (Oxf). 2018 May 30. doi: 10.1093/pubmed/fdy090. Fischer B1,2,3,4,5, Russell C1, Rehm J1,2,3,6,7,…Freedom WaresMay 30, 2018
Canna~Fangled Abstracts Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer’s Disease-Like Pathology. J Alzheimers Dis. 2018 May 28. doi: 10.3233/JAD-180230. Schmöle AC1, Lundt R1, Toporowski G1, Hansen…Freedom WaresMay 28, 2018
Canna~Fangled Abstracts Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer’s Disease. J Alzheimers Dis. 2018 May 26. doi: 10.3233/JAD-180137. Llorente-Ovejero A1, Manuel I1, Lombardero L1, Giralt…Freedom WaresMay 26, 2018
Canna~Fangled Abstracts Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease. J Neuroinflammation. 2018 May 24;15(1):158. doi: 10.1186/s12974-018-1174-9. López A1,2, Aparicio N1,3, Pazos MR1,3, Grande MT3,…Freedom WaresMay 24, 2018